GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » Mentor Capital Inc (OTCPK:MNTR) » Definitions » Median PS Value

Mentor Capital (Mentor Capital) Median PS Value : $0.00 (As of Jun. 01, 2024)


View and export this data going back to . Start your Free Trial

What is Mentor Capital Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Mentor Capital's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.097. Mentor Capital's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.

As of today (2024-06-01), Mentor Capital's share price is $0.058. Mentor Capital's Median PS Value is $0.00. Therefore, Mentor Capital's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Mentor Capital's Median PS Value or its related term are showing as below:

MNTR's Price-to-Median-PS-Value is not ranked *
in the Capital Markets industry.
Industry Median: 1.07
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Mentor Capital Median PS Value Historical Data

The historical data trend for Mentor Capital's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mentor Capital Median PS Value Chart

Mentor Capital Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mentor Capital Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mentor Capital's Median PS Value

For the Capital Markets subindustry, Mentor Capital's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mentor Capital's Price-to-Median-PS-Value Distribution in the Capital Markets Industry

For the Capital Markets industry and Financial Services sector, Mentor Capital's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Mentor Capital's Price-to-Median-PS-Value falls into.



Mentor Capital Median PS Value Calculation

Mentor Capital's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.097*0
=0.00

10-Year Median PS Ratio is 0.
Mentor Capital's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.097.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mentor Capital  (OTCPK:MNTR) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Mentor Capital's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.058/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mentor Capital Median PS Value Related Terms

Thank you for viewing the detailed overview of Mentor Capital's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Mentor Capital (Mentor Capital) Business Description

Traded in Other Exchanges
N/A
Address
5964 Campus Court, Plano, TX, USA, 75093
Mentor Capital Inc acquires and provides liquidity for medical and social use cannabis companies. The company is operating an acquisition and investment business. It operates through two segments namely the historic cannabis and medical marijuana segment, and the Company's legacy investment in WCI, which works with business park owners, governmental centers, and apartment complexes to reduce their facility-related operating costs. The cannabis and medical marijuana segment include the operation of subsidiaries in the Cannabis and medical marijuana sector. Mentor's focus is medical and the company seeks to facilitate the application of cannabis to cancer wasting, calming seizures, and Parkinson's disease, reducing ocular pressures from glaucoma, and blunting chronic pain.
Executives
David G. Carlile director 10901 BULLRUSH DRIVE, VENICE FL 34293
Lori Stansfield officer: Chief Financial Officer 903 N. TOWNER STREET, SANTA ANA CA 92703
Chester Billingsley director, 10 percent owner, officer: Chief Executive Officer 5964 CAMPUS COURT, PLANO TX 75093
Stan Shaul director 2586 CLAYBOURNE COURT, NEWBURY PARK CA 91320
Robert Bernhard Meyer director 24446 CASWELL COURT, LAGUNA NIGUEL CA 92677
Earl Kornbrekke director 458 DEHARO LANE, FRIDAY HARBOR WA 98250
James Blazeck director 536 OVERLOOK DRIVE, PITTSBURG PA 15216